Burning Rock Biotech annual return on equity
2021
2022
2023
2024
2025
Burning Rock Biotech Return on Equity (ROE) Growth & History (BNR)
Burning Rock Biotech's return on equity was −10.14% for fiscal 2025.
View full Burning Rock Biotech company overviewBurning Rock Biotech annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −10.14% | +40.43 pp |
| 2024 | 2024-12-31 | −50.57% | +16.10 pp |
| 2023 | 2023-12-31 | −66.68% | −5.12 pp |
| 2022 | 2022-12-31 | −61.56% | −23.71 pp |
| 2021 | 2021-12-31 | −37.85% | — |
Burning Rock Biotech return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Burning Rock Biotech's return on equity increased from −37.85% to −10.14%, a change of +27.71 percentage points.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Burning Rock Biotech source filings ↗